US20060013729A1
(en)
*
|
1991-02-14 |
2006-01-19 |
Glen Carey |
Fluid handling apparatus for an automated analyzer
|
US6436349B1
(en)
|
1991-03-04 |
2002-08-20 |
Bayer Corporation |
Fluid handling apparatus for an automated analyzer
|
US6498037B1
(en)
*
|
1991-03-04 |
2002-12-24 |
Bayer Corporation |
Method of handling reagents in a random access protocol
|
CA2384529C
(en)
*
|
1991-03-04 |
2007-01-02 |
Bayer Corporation |
Automated analyzer
|
DE4123818C2
(de)
*
|
1991-07-18 |
1994-05-19 |
Berthold Lab Prof Dr |
Vorrichtung zur Messung der Chemilumineszenz einer in einem Probengefäß befindlichen Probe
|
DK0584343T3
(da)
*
|
1992-03-10 |
1999-09-13 |
Jolla Cancer Res Found |
Rekombinant alkalisk phosphatase fra kalvetarme
|
EP1380842A3
(en)
|
1992-03-27 |
2009-12-30 |
Abbott Laboratories |
Test sample container assembly
|
US6399397B1
(en)
*
|
1992-09-14 |
2002-06-04 |
Sri International |
Up-converting reporters for biological and other assays using laser excitation techniques
|
EP0628823A4
(en)
*
|
1992-11-20 |
1996-05-08 |
Dainabot Co Ltd |
AUTOMATIC MULTI-CHANNEL IMMUNOTEST SYSTEM.
|
US5441894A
(en)
*
|
1993-04-30 |
1995-08-15 |
Abbott Laboratories |
Device containing a light absorbing element for automated chemiluminescent immunoassays
|
EP0651253A1
(en)
*
|
1993-11-02 |
1995-05-03 |
Abbott Laboratories |
Immunoassay for the detection of human autoantibodies
|
US5468649A
(en)
*
|
1994-02-15 |
1995-11-21 |
Abbott Laboratories |
Process for labeling acridinium to microparticles and application in an instrument
|
US20010055581A1
(en)
*
|
1994-03-18 |
2001-12-27 |
Lawrence Tamarkin |
Composition and method for delivery of biologically-active factors
|
US5599501A
(en)
*
|
1994-11-10 |
1997-02-04 |
Ciba Corning Diagnostics Corp. |
Incubation chamber
|
JPH08136546A
(ja)
*
|
1994-11-15 |
1996-05-31 |
Bio Sensor Kenkyusho:Kk |
物質分析法
|
ES2220982T3
(es)
*
|
1995-06-07 |
2004-12-16 |
Abbott Laboratories |
Peptidos destinados a la deteccion del vih-1.
|
US5686046A
(en)
*
|
1995-07-13 |
1997-11-11 |
Chiron Diagnostics Corporation |
Luminometer
|
US5720377A
(en)
*
|
1995-07-14 |
1998-02-24 |
Chiron Diagnostics Corporation |
Magnetic conveyor system
|
US5735387A
(en)
*
|
1995-07-14 |
1998-04-07 |
Chiron Diagnostics Corporation |
Specimen rack handling system
|
US6501549B1
(en)
|
1995-12-05 |
2002-12-31 |
University Of Utah Research Foundation |
Method of measuring chemical concentration based on spatial separation and resolution of luminescence
|
US20050202499A1
(en)
|
1996-10-31 |
2005-09-15 |
Billing-Medel Patricia A. |
Reagents and methods useful for detecting diseases of the breast
|
US6056923A
(en)
*
|
1997-06-25 |
2000-05-02 |
Clmp, Inc. |
Dual injector for chemiluminescence immunoanalyzing system
|
US6846905B2
(en)
|
1997-08-15 |
2005-01-25 |
Abbott Laboratories |
Antigen constructs useful in the detection and differentiation of antibodies to HIV
|
US7229841B2
(en)
|
2001-04-30 |
2007-06-12 |
Cytimmune Sciences, Inc. |
Colloidal metal compositions and methods
|
US6203974B1
(en)
|
1998-09-03 |
2001-03-20 |
Abbott Laboratories |
Chemiluminescent immunoassay for detection of antibodies to various viruses
|
US6794156B2
(en)
*
|
1999-05-10 |
2004-09-21 |
Applera Corporation |
Cell growth, induction and lysis in an antibody-coated microplate for use in an ELISA
|
US6686171B2
(en)
*
|
1999-05-10 |
2004-02-03 |
Tropix, Inc. |
Competitive chemiluminescent assay for cyclic nucleotide monophosphates
|
ES2165320B1
(es)
*
|
2000-05-03 |
2003-06-16 |
Dentaid S L |
Dispositivo optico para la cuantificacion de compuestos volatiles de azufre (cvs) a traves de medidas de absorcion/reflectancia.
|
AU2002231736A1
(en)
|
2000-12-22 |
2002-07-08 |
Max-Planck-Gesellschaft Zur Forderung Der Wissenschaften E.V. |
Use of repulsive guidance molecule (rgm) and its modulators
|
DE10136865B4
(de)
*
|
2001-07-28 |
2007-11-15 |
Berthold Technologies Gmbh & Co. Kg |
Vorrichtung zur Messung der Chemilumineszenz
|
US20040024193A1
(en)
|
2002-07-26 |
2004-02-05 |
Williams Gregg T. |
Method of detecting and quantifying hepatitis C virus
|
DE60330877D1
(de)
|
2002-07-26 |
2010-02-25 |
Abbott Lab |
Verfahren zum nachweis und zur quantifizierung von hepatitis-c-virus
|
US7920906B2
(en)
|
2005-03-10 |
2011-04-05 |
Dexcom, Inc. |
System and methods for processing analyte sensor data for sensor calibration
|
US9247900B2
(en)
|
2004-07-13 |
2016-02-02 |
Dexcom, Inc. |
Analyte sensor
|
CN1960825A
(zh)
*
|
2004-01-28 |
2007-05-09 |
细胞免疫科学公司 |
官能化胶态金属组合物和方法
|
US20060020192A1
(en)
|
2004-07-13 |
2006-01-26 |
Dexcom, Inc. |
Transcutaneous analyte sensor
|
WO2006127694A2
(en)
|
2004-07-13 |
2006-11-30 |
Dexcom, Inc. |
Analyte sensor
|
US20070037232A1
(en)
|
2005-03-31 |
2007-02-15 |
Barasch Jonathan M |
Detection of NGAL in chronic renal disease
|
US8624027B2
(en)
|
2005-05-12 |
2014-01-07 |
Abbvie Inc. |
Combination therapy for treating cancer and diagnostic assays for use therein
|
ES2542501T3
(es)
*
|
2005-09-30 |
2015-08-06 |
Abbvie Deutschland Gmbh & Co Kg |
Dominios de unión de proteínas de la familia de proteínas de moléculas de orientación repulsiva (RGM) y fragmentos funcionales de las mismas, así como su uso
|
US20080220448A1
(en)
*
|
2006-09-01 |
2008-09-11 |
Blincko Stuart J |
Antigenic protein conjugates and process for preparing same
|
US8865398B2
(en)
|
2006-09-01 |
2014-10-21 |
Abbott Laboratories |
Combination hepatitis C virus antigen and antibody detection method
|
US7776605B2
(en)
|
2006-10-26 |
2010-08-17 |
Abbott Laboratories |
Assay for cardiac troponin autoantibodies
|
US20080305512A1
(en)
*
|
2006-10-26 |
2008-12-11 |
Mattingly Phillip G |
Assay for cardiac troponin autoantibodies
|
MX2009004460A
(es)
*
|
2006-10-26 |
2009-07-09 |
Abbott Lab |
Inmunoensayo de analitos en muestras que contienen anticuerpos anti-analito endogenos.
|
KR100824388B1
(ko)
*
|
2006-12-06 |
2008-04-22 |
한국타이어 주식회사 |
화학발광을 이용한 타이어 부위 별 노화측정방법
|
US7858924B2
(en)
|
2006-12-12 |
2010-12-28 |
Abbott Laboratories, Inc. |
Device for use in normalizing readings on a testing machine
|
US7914999B2
(en)
|
2006-12-29 |
2011-03-29 |
Abbott Laboratories |
Non-denaturing lysis reagent
|
JP5026849B2
(ja)
*
|
2007-04-20 |
2012-09-19 |
株式会社日立製作所 |
化学発光計測装置
|
US20080280377A1
(en)
|
2007-05-08 |
2008-11-13 |
Abbott Laboratories |
Human b-type natriuretic peptide assay having reduced cross-reactivity with other peptide forms
|
ATE535813T1
(de)
*
|
2007-05-24 |
2011-12-15 |
Abbott Lab |
Reduzierte kreuzreaktivität mit hydrophoben arzneistoffanalyt-stoffwechselprodukten zeigende immuntestverfahren
|
US20090053736A1
(en)
*
|
2007-08-21 |
2009-02-26 |
Mattingly Phillip G |
Homogeneous Chemiluminescent Immunoassay for Analysis of Iron Metalloproteins
|
US7608361B2
(en)
*
|
2007-08-22 |
2009-10-27 |
Stauffer John E |
Alkali metal battery
|
US20090068635A1
(en)
*
|
2007-09-06 |
2009-03-12 |
Muerhoff Anthony S |
Indirectly labelled assay conjugates and methods of preparing and using same
|
EP2033971A1
(de)
*
|
2007-09-06 |
2009-03-11 |
Abbott GmbH & Co. KG |
Bone Morphogenetic Protein (BMP)-bindende Domänen von Proteinen der Repulsive Guidance Molecule (RGM) Proteinfamilie und funktionale Fragmente davon sowie deren Verwendung
|
US20100136520A1
(en)
*
|
2007-09-13 |
2010-06-03 |
Abbott Laboratories |
Detecting hepatitis b virus
|
US8138318B2
(en)
|
2007-09-13 |
2012-03-20 |
Abbott Laboratories |
Hepatitis B pre-S2 nucleic acid
|
US20090098531A1
(en)
*
|
2007-09-13 |
2009-04-16 |
Abbott Laboratories |
Detecting hepatitis b virus
|
US20110014118A1
(en)
*
|
2007-09-21 |
2011-01-20 |
Lawrence Tamarkin |
Nanotherapeutic colloidal metal compositions and methods
|
JP2011520769A
(ja)
*
|
2007-09-21 |
2011-07-21 |
サイトイミューン サイエンシズ インコーポレイテッド |
ナノ治療コロイド金属組成物および方法
|
WO2009052392A1
(en)
|
2007-10-19 |
2009-04-23 |
Abbott Laboratories |
Immunoassays and kits for the detection of ngal
|
US20100267055A1
(en)
*
|
2007-10-21 |
2010-10-21 |
Abbott Laboratories |
One-step immunoassays exhibiting increased sensitivity and specificity
|
US8283124B2
(en)
*
|
2007-10-25 |
2012-10-09 |
Abbott Laboratories |
Compositions for detecting antibodies to Babesia microti and methods of uses thereof
|
WO2009078875A1
(en)
|
2007-12-19 |
2009-06-25 |
Abbott Laboratories |
Immunosuppressant drug extraction reagent for immunoassays
|
CN101387650B
(zh)
*
|
2007-12-20 |
2012-06-27 |
北京科美生物技术有限公司 |
全自动板式发光仪及其发光检测方法
|
DE202008009859U1
(de)
*
|
2007-12-21 |
2009-03-05 |
Berthold Technologies Gmbh & Co. Kg |
Vorrichtung zur wahlweisen Messung von insbesondere Lumineszenz- und/oder Fluoreszenzstrahlung
|
US20090203038A1
(en)
*
|
2007-12-27 |
2009-08-13 |
Abbott Laboratories |
Negative Mimic Antibody For Use as a Blocking Reagent In BNP Immunoassays
|
WO2009086398A2
(en)
*
|
2007-12-27 |
2009-07-09 |
Abbott Laboratories |
Anti-t. cruzi antibodies and methods of use
|
US8962803B2
(en)
|
2008-02-29 |
2015-02-24 |
AbbVie Deutschland GmbH & Co. KG |
Antibodies against the RGM A protein and uses thereof
|
US8268981B2
(en)
*
|
2008-03-06 |
2012-09-18 |
Abbott Laboratories |
Plasmodium malariae and plasmodium ovale genes and uses thereof
|
US8030471B2
(en)
*
|
2008-03-06 |
2011-10-04 |
Abbott Laboratories |
Plasmodium malariae and Plasmodium ovale genes and uses thereof
|
US9029508B2
(en)
|
2008-04-29 |
2015-05-12 |
Abbvie Inc. |
Dual variable domain immunoglobulins and uses thereof
|
US20090286329A1
(en)
*
|
2008-05-19 |
2009-11-19 |
Abbott Laboratoires |
Isolated human autoantibodies to natriuretic peptides and methods and kits for detecting human autoantibodies to natriuretic peptides
|
US20090286256A1
(en)
*
|
2008-05-19 |
2009-11-19 |
Abbott Laboratories |
Isolated human autoantibodies to natriuretic peptides and methods and kits for detecting human autoantibodies to natriuretic peptides
|
EP3002299A1
(en)
|
2008-06-03 |
2016-04-06 |
AbbVie Inc. |
Dual variable domain immunoglobulins and uses thereof
|
US20100015655A1
(en)
*
|
2008-07-17 |
2010-01-21 |
Abbott Laboratories |
Methods and Kits for Detecting and Quantifying Damage Caused by a Parasite
|
WO2010028014A1
(en)
|
2008-09-03 |
2010-03-11 |
Abbott Laboratories |
Assays and kits for determining hiv-1 tropism
|
US20100105150A1
(en)
*
|
2008-10-24 |
2010-04-29 |
Abbott Laboratories |
Isolated human autoantibodies to neutrophil gelatinase-associated lipocalin (ngal) and methods and kits for the detection of human autoantibodies to ngal
|
US8168165B2
(en)
|
2008-12-23 |
2012-05-01 |
Abbott Laboratories |
Alkylated interleukin-18 compositions
|
US8349325B2
(en)
|
2008-12-23 |
2013-01-08 |
Abbott Laboratories |
Soluble FMS-like tyrosine kinase-1 (sFLT-1) antibody and related composition, kit, methods of using, and materials and method for making
|
US8241915B2
(en)
*
|
2009-01-14 |
2012-08-14 |
Abbott Laboratories |
Methods and kits for detecting hemoglobin in test samples
|
WO2010088470A1
(en)
|
2009-01-31 |
2010-08-05 |
Abbott Laboratories |
Markers to predict and monitor response to aurora kinase b inhibitor therapy
|
CA2751293A1
(en)
*
|
2009-02-11 |
2010-08-19 |
Abbott Laboratories |
Methods and compositions for identifying, classifying and monitoring subject having bcl-2 family inhibitor-resistant tumors and cancers
|
US8030026B2
(en)
|
2009-02-24 |
2011-10-04 |
Abbott Laboratories |
Antibodies to troponin I and methods of use thereof
|
EP2810652A3
(en)
|
2009-03-05 |
2015-03-11 |
AbbVie Inc. |
IL-17 binding proteins
|
US8283162B2
(en)
|
2009-03-10 |
2012-10-09 |
Abbott Laboratories |
Antibodies relating to PIVKAII and uses thereof
|
US8063193B2
(en)
|
2009-03-27 |
2011-11-22 |
Abbott Laboratories |
Nucleotide and amino acid sequences encoding an exported protein 1 derived from Plasmodium vivax and uses thereof
|
CN201404734Y
(zh)
*
|
2009-04-28 |
2010-02-17 |
厦门市毕恩生物技术有限公司 |
底部控制式标本过滤容器
|
US20100291709A1
(en)
*
|
2009-05-13 |
2010-11-18 |
Abbott Laboratories |
Human nt-pro b-type natriuretic peptide assay having reduced cross-reactivity with other peptide forms
|
JP2012531926A
(ja)
|
2009-06-30 |
2012-12-13 |
アボット ラボラトリーズ |
Xmrv感染のマーカーとその使用
|
US8623358B2
(en)
|
2009-08-29 |
2014-01-07 |
Abbvie Inc. |
Therapeutic DLL4 binding proteins
|
US8501420B2
(en)
*
|
2009-08-31 |
2013-08-06 |
Abbott Laboratories |
Biomarkers for prediction of major adverse cardiac events and uses thereof
|
JP5205354B2
(ja)
*
|
2009-09-30 |
2013-06-05 |
富士フイルム株式会社 |
クロマトグラフ測定装置
|
US8455212B2
(en)
*
|
2009-11-21 |
2013-06-04 |
Abbott Laboratories |
Assays for human NT-pro B-type natriuretic peptide, human pro B-type natriuretic peptide and human B-type natriuretic peptide
|
US8835120B2
(en)
*
|
2009-12-02 |
2014-09-16 |
Abbott Laboratories |
Assay for cardiac troponin-T (cTnT)
|
US8652788B2
(en)
*
|
2009-12-02 |
2014-02-18 |
Abbott Laboratories |
Assay for diagnosis of cardiac myocyte damage
|
US8183002B2
(en)
*
|
2009-12-03 |
2012-05-22 |
Abbott Laboratories |
Autoantibody enhanced immunoassays and kits
|
US20110136141A1
(en)
|
2009-12-03 |
2011-06-09 |
Abbott Laboratories |
Peptide reagents and method for inhibiting autoantibody antigen binding
|
SG181563A1
(en)
*
|
2009-12-08 |
2012-07-30 |
Abbott Gmbh & Co Kg |
Monoclonal antibodies against the rgm a protein for use in the treatment of retinal nerve fiber layer degeneration
|
EP2542582A4
(en)
|
2010-03-02 |
2013-12-04 |
Abbvie Inc |
THERAPEUTIC PROTEINS LINKING TO DLL4
|
US20110229921A1
(en)
*
|
2010-03-18 |
2011-09-22 |
Abbott Laboratories |
METHODS OF ASSAYING URINARY NEUTROPHIL GELATINASE-ASSOCIATED LIPOCALIN (uNGAL) IN THE PROGNOSIS OF CADAVERIC KIDNEY TRANSPLANT FUNCTION IN A PATIENT, INCLUDING A PATIENT DIAGNOSED WITH DELAYED GRAFT FUNCTION (DGF), A METHOD OF ASSAYING uNGAL IN THE ASSESSMENT OF RISK OF DGF IN A PATIENT DIAGNOSED WITH EARLY GRAFT FUNCTION (EGF), AND RELATED KITS
|
WO2011129382A1
(en)
|
2010-04-16 |
2011-10-20 |
Abbott Japan Co. Ltd. |
Methods and reagents for diagnosing rheumatoid arthritis
|
JP5524698B2
(ja)
*
|
2010-04-27 |
2014-06-18 |
株式会社日立ハイテクノロジーズ |
自動分析装置
|
CN102236013A
(zh)
*
|
2010-04-28 |
2011-11-09 |
上海捷瑞医用试剂有限公司 |
化学发光免疫分析仪用浓缩缓冲液及其制备方法
|
WO2011140234A1
(en)
|
2010-05-07 |
2011-11-10 |
Abbott Laboratories |
Methods for predicting sensitivity to treatment with a targeted tyrosine kinase inhibitor
|
US20120190563A1
(en)
|
2010-05-07 |
2012-07-26 |
Abbott Laboratories |
Methods for predicting sensitivity to treatment with a targeted tyrosine kinase inhibitor
|
AU2011252883B2
(en)
|
2010-05-14 |
2015-09-10 |
Abbvie Inc. |
IL-1 binding proteins
|
US9551714B2
(en)
|
2010-06-25 |
2017-01-24 |
Abbott Laboratories |
Materials and methods for assay of anti-hepatitis C virus (HCV) antibodies
|
WO2012006500A2
(en)
|
2010-07-08 |
2012-01-12 |
Abbott Laboratories |
Monoclonal antibodies against hepatitis c virus core protein
|
UY33492A
(es)
|
2010-07-09 |
2012-01-31 |
Abbott Lab |
Inmunoglobulinas con dominio variable dual y usos de las mismas
|
US9120862B2
(en)
|
2010-07-26 |
2015-09-01 |
Abbott Laboratories |
Antibodies relating to PIVKA-II and uses thereof
|
CN103298834A
(zh)
|
2010-08-03 |
2013-09-11 |
Abbvie公司 |
双重可变结构域免疫球蛋白及其用途
|
WO2012024513A2
(en)
|
2010-08-18 |
2012-02-23 |
Abbott Laboratories |
Molecular detection of xmrv infection
|
WO2012024518A1
(en)
|
2010-08-18 |
2012-02-23 |
Abbott Laboratories |
Molecular detection of xmrv infection
|
BR112013004581A2
(pt)
|
2010-08-26 |
2017-06-27 |
Abbvie Inc |
imunoglobulinas de domínio variável dual e seus usos
|
US20120115244A1
(en)
|
2010-11-09 |
2012-05-10 |
Abbott Laboratories |
Materials and methods for immunoassay of pterins
|
KR20130133247A
(ko)
|
2010-12-21 |
2013-12-06 |
애브비 인코포레이티드 |
Il-1-알파 및 -베타 이특이적 이원 가변 도메인 면역글로불린 및 이의 용도
|
SG10201600531TA
(en)
|
2011-01-24 |
2016-02-26 |
Univ Singapore |
Pathogenic mycobacteria-derived mannose-capped lipoarabinomannan antigen binding proteins
|
AU2012229156A1
(en)
|
2011-03-11 |
2013-10-31 |
Board Of Regents Of The University Of Nebraska |
Biomarker for coronary artery disease
|
CN103620409B
(zh)
|
2011-05-20 |
2017-04-12 |
阿波特日本有限公司 |
用于减少非特异性结合的免疫检验方法和试剂
|
US10641768B2
(en)
|
2011-07-08 |
2020-05-05 |
Abbott Japan Co. Ltd. |
Methods and kits for decreasing interferences from leukocytes in specific binding assays
|
WO2013009705A2
(en)
|
2011-07-09 |
2013-01-17 |
The Trustees Of Columbia University In The City Of New York |
Biomarkers, methods, and compositions for inhibiting a multi-cancer mesenchymal transition mechanism
|
AU2012328917B2
(en)
|
2011-10-24 |
2017-05-25 |
Abbvie Inc. |
Bispecific immunobinders directed against TNF and IL-17
|
WO2013063095A1
(en)
|
2011-10-24 |
2013-05-02 |
Abbvie Inc. |
Immunobinders directed against sclerostin
|
CA2855840C
(en)
|
2011-12-14 |
2023-08-29 |
AbbVie Deutschland GmbH & Co. KG |
Composition and method for the diagnosis and treatment of iron-related disorders
|
EP2791175A2
(en)
|
2011-12-14 |
2014-10-22 |
Abbvie Deutschland GmbH & Co. KG |
Composition and method for the diagnosis and treatment of iron-related disorders
|
AR090047A1
(es)
|
2011-12-30 |
2014-10-15 |
Abbvie Inc |
Dominio variable dual de inmunoglobulinas y sus usos
|
AR089529A1
(es)
|
2011-12-30 |
2014-08-27 |
Abbvie Inc |
Proteinas de union especificas duales dirigidas contra il-13 y/o il-17
|
US8993248B2
(en)
|
2011-12-31 |
2015-03-31 |
Abbott Laboratories |
Truncated human vitamin D binding protein and mutation and fusion thereof and related materials and methods of use
|
RU2644337C2
(ru)
|
2012-01-27 |
2018-02-08 |
Эббви Дойчланд Гмбх Унд Ко. Кг |
Композиции и способы диагностики и лечения заболеваний, ассоциированных с дегенерацией нейритов
|
WO2014011955A2
(en)
|
2012-07-12 |
2014-01-16 |
Abbvie, Inc. |
Il-1 binding proteins
|
WO2014031327A2
(en)
*
|
2012-08-20 |
2014-02-27 |
Siemens Healthcare Diagnostics Inc. |
Clam-shell luminometer
|
CN102798718A
(zh)
*
|
2012-08-31 |
2012-11-28 |
福建省洪诚生物药业有限公司 |
乙肝病毒前s1抗原检测试剂盒及其制备方法
|
PE20151179A1
(es)
|
2012-11-01 |
2015-09-12 |
Abbvie Inc |
Inmunoglobulinas de dominio variable dual anti-vegf/dll4 y usos de las mismas
|
WO2014089209A2
(en)
|
2012-12-04 |
2014-06-12 |
Abbvie, Inc. |
Blood-brain barrier (bbb) penetrating dual specific binding proteins
|
WO2014106001A2
(en)
|
2012-12-28 |
2014-07-03 |
Abbvie, Inc. |
Dual specific binding proteins having a receptor sequence
|
US9856319B2
(en)
|
2012-12-28 |
2018-01-02 |
Abbvie Inc. |
Monovalent binding proteins
|
EP2948475A2
(en)
|
2013-01-23 |
2015-12-02 |
AbbVie Inc. |
Methods and compositions for modulating an immune response
|
US9488663B2
(en)
|
2013-03-14 |
2016-11-08 |
Abbott Point Of Care Inc. |
Electrochemical methods and devices for amending urine samples for immunosensor detection
|
US9194873B2
(en)
|
2013-03-14 |
2015-11-24 |
Abbott Laboratories |
HCV antigen-antibody combination assay and methods and compositions for use therein
|
US9651547B2
(en)
|
2013-03-14 |
2017-05-16 |
Abbott Point Of Care Inc. |
Electrochemical methods and devices for amending urine samples for immunosensor detection
|
US9790478B2
(en)
|
2013-03-14 |
2017-10-17 |
Abbott Laboratories |
HCV NS3 recombinant antigens and mutants thereof for improved antibody detection
|
CN105378099B
(zh)
|
2013-03-14 |
2021-05-11 |
雅培制药有限公司 |
Hcv核心脂质结合结构域单克隆抗体
|
US20140271453A1
(en)
|
2013-03-14 |
2014-09-18 |
Abbott Laboratories |
Methods for the early detection of lung cancer
|
BR112015023797A2
(pt)
|
2013-03-15 |
2017-10-24 |
Abbvie Inc |
proteínas de ligação de especificidade dupla dirigidas contra il-1b e/ou il-17
|
US9005901B2
(en)
|
2013-03-15 |
2015-04-14 |
Abbott Laboratories |
Assay with internal calibration
|
US9469686B2
(en)
|
2013-03-15 |
2016-10-18 |
Abbott Laboratories |
Anti-GP73 monoclonal antibodies and methods of obtaining the same
|
US9157910B2
(en)
|
2013-03-15 |
2015-10-13 |
Abbott Laboratories |
Assay with increased dynamic range
|
TW201446800A
(zh)
|
2013-03-15 |
2014-12-16 |
Abbvie Inc |
針對TNFα之雙特異性結合蛋白
|
WO2015031626A1
(en)
|
2013-08-28 |
2015-03-05 |
Abbvie Inc. |
Soluble cmet assay
|
BR112016007592A2
(pt)
|
2013-10-06 |
2018-01-23 |
Abbvie Inc |
proteína de ligação biespecífica que se liga a pelo menos dois alvos, conjugado de proteína de ligação biespecífica, composição farmacêutica, ácido nucleico isolado, vetor, célula hospedeira, método para produzir uma proteína de ligação biespecífica, método para determinar a reatividade de um paciente a um agente terapêutico que tem capacidade para modular a atividade de um tlr, método para ativar ou inibir células responsivas a tlr9, método para tratar um paciente que precisa de ativação de tlr9 ou inibição de tlr e método para identificar um inibidor ou estimulador de sinalização de tlr
|
KR102056963B1
(ko)
|
2013-12-30 |
2019-12-17 |
에피맙 바이오테라퓨틱스 인코포레이티드 |
Fabs-인-탠덤 면역글로불린 및 이의 용도
|
WO2015191934A2
(en)
|
2014-06-11 |
2015-12-17 |
Abbvie Inc. |
Blood-brain barrier (bbb) penetrating dual specific binding proteins for treating brain and neurological diseases
|
JP2017521654A
(ja)
|
2014-06-27 |
2017-08-03 |
アボット・ラボラトリーズAbbott Laboratories |
ヒトペギウイルス2(HPgV−2)を検出するための組成物および方法
|
WO2016069762A2
(en)
|
2014-10-29 |
2016-05-06 |
Abbott Laboratories |
Subject anti-hcv antibody detection assays employing ns3 capture peptides
|
WO2016094881A2
(en)
|
2014-12-11 |
2016-06-16 |
Abbvie Inc. |
Lrp-8 binding proteins
|
WO2016160976A2
(en)
|
2015-03-30 |
2016-10-06 |
Abbvie Inc. |
Monovalent tnf binding proteins
|
TW201710286A
(zh)
|
2015-06-15 |
2017-03-16 |
艾伯維有限公司 |
抗vegf、pdgf及/或其受體之結合蛋白
|
US20170089905A1
(en)
|
2015-09-28 |
2017-03-30 |
Abbott Japan Co., Ltd. |
Methods of diagnosing hepatocellular carcinoma and pancreatic cancer
|
CA3011746A1
(en)
|
2016-02-06 |
2017-08-10 |
Epimab Biotherapeutics, Inc. |
Fabs-in-tandem immunoglobulin and uses thereof
|
US20170363620A1
(en)
|
2016-06-17 |
2017-12-21 |
Abbott Laboratories |
BIOMARKERS TO PREDICT NEW ONSET HEART FAILURE WITH PRESERVED EJECTION FRACTION (HFpEF)
|
MX2019001134A
(es)
*
|
2016-07-29 |
2019-04-11 |
Inst Tecnologico Estudios Superiores Monterrey |
Sistemas y metodos para la deteccion de reacciones quimioluminiscentes.
|
EP3279667A1
(en)
|
2016-08-02 |
2018-02-07 |
Abbott Laboratories |
Cardiac troponin i and copeptin as biomarkers for short-term mortality in acute exacerbation of chronic obstructive pulmonary disease (aecopd)
|
US10722882B2
(en)
*
|
2016-08-03 |
2020-07-28 |
Pierce Biotechnology, Inc. |
Chemiluminescent and fluorescent substrate pads and uses thereof
|
US20180106800A1
(en)
|
2016-10-03 |
2018-04-19 |
Abbott Laboratories |
Methods of assessing uch-l1 status in patient samples
|
CA3052513A1
(en)
|
2017-03-23 |
2018-09-27 |
Abbott Laboratories |
Methods for aiding in the diagnosis and determination of the extent of traumatic brain injury in a human subject using the early biomarker ubiquitin carboxy-terminal hydrolase l1
|
CN106980024A
(zh)
*
|
2017-03-28 |
2017-07-25 |
杭州凯坤科技有限公司 |
一种全自动光激化学发光检测仪
|
EP3610268A1
(en)
|
2017-04-15 |
2020-02-19 |
Abbott Laboratories |
Methods for aiding in the hyperacute diagnosis and determination of traumatic brain injury in a human subject using early biomarkers
|
JP7080899B2
(ja)
|
2017-04-28 |
2022-06-06 |
アボット・ラボラトリーズ |
同じヒト対象に由来する少なくとも2つの試料に対して早期バイオマーカーを使用する、外傷性脳損傷の超急性の診断及び決定の一助となるための方法
|
CA3078725A1
(en)
|
2017-05-25 |
2018-11-29 |
Abbott Laboratories |
Methods for aiding in the determination of whether to perform imaging on a human subject who has sustained or may have sustained an injury to the head using early biomarkers
|
AU2018275236A1
(en)
|
2017-05-30 |
2019-10-31 |
Abbott Laboratories |
Methods for aiding in diagnosing and evaluating a mild traumatic brain injury in a human subject using cardiac troponin I
|
US11169159B2
(en)
|
2017-07-03 |
2021-11-09 |
Abbott Laboratories |
Methods for measuring ubiquitin carboxy-terminal hydrolase L1 levels in blood
|
AU2018378084A1
(en)
|
2017-12-09 |
2020-05-14 |
Abbott Laboratories |
Methods for aiding in diagnosing and evaluating a traumatic brain injury in a human subject using a combination of GFAP and UCH-L1
|
BR112019028254A2
(pt)
|
2017-12-09 |
2020-07-14 |
Abbott Laboratories |
métodos para ajudar no diagnóstico e avaliação de um paciente que sofreu uma lesão ortopédica e que sofreu ou pode ter sofrido uma lesão na cabeça, tal como uma lesão cerebral traumática (lct) leve, usando a proteína ácida fibrilar glial (gfap) e/ou a hidrolase carbóxi-terminal da ubiquitina l1 (uch-l1)
|
EP3732489A1
(en)
|
2017-12-29 |
2020-11-04 |
Abbott Laboratories |
Novel biomarkers and methods for diagnosing and evaluating traumatic brain injury
|
WO2019151468A1
(ja)
*
|
2018-02-02 |
2019-08-08 |
日本ケミファ株式会社 |
生化学反応用基体及び分析装置
|
AR114436A1
(es)
|
2018-04-30 |
2020-09-02 |
Takeda Pharmaceuticals Co |
Proteínas de unión al receptor de cannabinoides tipo 1 (cb1) y usos de las mismas
|
WO2019213619A1
(en)
|
2018-05-04 |
2019-11-07 |
Abbott Laboratories |
Hbv diagnostic, prognostic, and therapeutic methods and products
|
EP3931573A1
(en)
|
2019-03-01 |
2022-01-05 |
Abbott Laboratories |
Methods for predicting major adverse cardiovascular events in subjects with coronary artery disease
|
EP4010707A1
(en)
|
2019-08-07 |
2022-06-15 |
Abbott Laboratories |
Methods for detecting assay interferents and increasing dynamic range
|
EP4136459A1
(en)
|
2020-04-13 |
2023-02-22 |
Abbott Laboratories |
Methods, complexes and kits for detecting or determining an amount of a ss-coronavirus antibody in a sample
|
CN111693514B
(zh)
*
|
2020-05-07 |
2022-07-05 |
四川轻化工大学 |
一种利用在线式液气转换的在线检测装置及方法
|
WO2022031804A1
(en)
|
2020-08-04 |
2022-02-10 |
Abbott Laboratories |
Improved methods and kits for detecting sars-cov-2 protein in a sample
|
US20220170948A1
(en)
|
2020-12-01 |
2022-06-02 |
Abbott Laboratories |
Use of one or more biomarkers to determine traumatic brain injury (tbi) in a human subject having received a head computerized tomography scan that is negative for a tbi
|
WO2023102384A1
(en)
|
2021-11-30 |
2023-06-08 |
Abbott Laboratories |
Use of one or more biomarkers to determine traumatic brain injury (tbi) in a subject having received a head computerized tomography scan that is negative for a tbi
|
WO2022147147A1
(en)
|
2020-12-30 |
2022-07-07 |
Abbott Laboratories |
Methods for determining sars-cov-2 antigen and anti-sars-cov-2 antibody in a sample
|
WO2022147178A1
(en)
|
2020-12-30 |
2022-07-07 |
Abbott Laboratories |
Improved methods, reagents and kits for detergent-based inactivation of betacoronavirus prior to and/or while assessing a biological sample for sars-cov-2 antigen or antibody
|
BR112023024169A2
(pt)
|
2021-05-18 |
2024-02-06 |
Abbott Lab |
Métodos para avaliar lesão cerebral em um indivíduo pediátrico
|
EP4356129A1
(en)
|
2021-06-14 |
2024-04-24 |
Abbott Laboratories |
Methods of diagnosing or aiding in diagnosis of brain injury caused by acoustic energy, electromagnetic energy, an over pressurization wave, and/or blast wind
|
WO2023028186A1
(en)
|
2021-08-27 |
2023-03-02 |
Abbott Laboratories |
Methods for detecting immunoglobulin g, subclass 4 (igg4) in a biological sample
|
WO2023034777A1
(en)
|
2021-08-31 |
2023-03-09 |
Abbott Laboratories |
Methods and systems of diagnosing brain injury
|
CA3232176A1
(en)
|
2021-09-30 |
2023-04-06 |
Beth MCQUISTON |
Methods and systems of diagnosing brain injury
|
US20230213536A1
(en)
|
2021-12-28 |
2023-07-06 |
Abbott Laboratories |
Use of biomarkers to determine sub-acute traumatic brain injury (tbi) in a subject having received a head computerized tomography (ct) scan that is negative for a tbi or no head ct scan
|
WO2024044288A1
(en)
|
2022-08-26 |
2024-02-29 |
Abbott Laboratories |
Use of cardiac troponin and galectin-3 to differentiate myocardial infarction type i and type ii
|
WO2024059692A1
(en)
|
2022-09-15 |
2024-03-21 |
Abbott Laboratories |
Hbv diagnostic, prognostic, and therapeutic methods and products
|
WO2024059708A1
(en)
|
2022-09-15 |
2024-03-21 |
Abbott Laboratories |
Biomarkers and methods for differentiating between mild and supermild traumatic brain injury
|
WO2024102383A1
(en)
|
2022-11-10 |
2024-05-16 |
Abbott Laboratories |
Methods of identifying macrotroponin in biological samples
|